Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

Company Overview

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is a leading global pharmacy-led health and wellbeing company that operates through three primary segments: Retail Pharmacy USA, International Pharmacy Retail, and Pharmaceutical Wholesale. The company serves millions of customers daily by providing prescription filling, health and wellness products, beauty and personal care items, and a range of healthcare services. Leveraging its extensive retail footprint and digital platforms, Walgreens Boots Alliance aims to offer convenient access to care, both in physical stores and online, ensuring continuity in patient support and medication management.

Founded through the merger of Walgreens, established in 1901 by Charles R. Walgreen, and Alliance Boots, which traces its origins to John Boot’s pharmacy in Nottingham in 1849, the company brings together more than a century of retail and pharmaceutical expertise. Since the merger in 2014, Walgreens Boots Alliance has expanded its presence across the United States, Europe, Latin America, and the Asia-Pacific region. The company’s diversified operations include wholesale distribution to independent pharmacies, hospitals, and clinics, positioning it as a critical link in the global healthcare supply chain.

Walgreens Boots Alliance offers an array of products and services, including over-the-counter medicines, consumer health and beauty products, clinical services such as immunizations and health checks, and prescription delivery. The company has invested in digital innovations like telehealth consultations, mobile prescription ordering, and personalized health programs designed to improve patient adherence and outcomes. Additionally, strategic partnerships with healthcare providers and technology firms bolster its integrated care model.

Under the leadership of Executive Chairman Stefano Pessina and Chief Executive Officer Rosalind Brewer, Walgreens Boots Alliance continues to pursue growth through strategic alliances, cost efficiencies, and expansion of its healthcare services. With a commitment to community health and sustainability, the company focuses on enhancing patient experiences, reducing healthcare costs, and promoting responsible business practices across its global operations.

Key Stats

• Today's Range: $11.43 to $11.49
• 50-Day Range: $10.93 to $11.49
• 52-Week Range: $8.08 to $13.25
• Volume: 6.66 million shs
• Average Volume: 19.70 million shs
• Market Capitalization: $9.93 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.59
• Consensus Rating: Reduce

Walgreens Boots Alliance Stock Analysis - MarketRank™

Walgreens Boots Alliance scored higher than 62% of companies evaluated by MarketBeat, and ranked 138th out of 213 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Walgreens Boots Alliance has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on 2 buy ratings, 6 hold ratings, and 4 sell ratings.

Amount of Analyst Coverage

Walgreens Boots Alliance has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -8.75%

Earnings Growth

Earnings for Walgreens Boots Alliance are expected to decrease by -8.75% in the coming year, from $1.60 to $1.46 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Walgreens Boots Alliance is -1.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Walgreens Boots Alliance is -1.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Walgreens Boots Alliance has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Walgreens Boots Alliance has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.69% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 18.44%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Walgreens Boots Alliance does not currently pay a dividend.

Dividend Growth

Walgreens Boots Alliance does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 68.49% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 2.3 / 5
• Environmental Score: -2.09

Percentage of Shares Shorted

2.69% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 18.44%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.54

News Sentiment

Walgreens Boots Alliance has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 28 news articles for Walgreens Boots Alliance this week, compared to 30 articles on an average week.

Search Interest

24 people have searched for WBA on MarketBeat in the last 30 days. This is an increase of 4% compared to the previous 30 days.

MarketBeat Follows

8 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Walgreens Boots Alliance insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,163,161.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

17.50% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.59% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

WBA Stock Analysis - Frequently Asked Questions

How have WBA shares performed this year?

Walgreens Boots Alliance's stock was trading at $9.33 at the beginning of 2025. Since then, WBA shares have increased by 23.0% and is now trading at $11.4750.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) posted its earnings results on Thursday, June, 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance's revenue was up 7.2% on a year-over-year basis.

Does Walgreens Boots Alliance have any subsidiaries?

Walgreens Boots Alliance subsidiaries include Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and more.

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's top institutional shareholders include Kera Capital Partners Inc.. Insiders that own company stock include Stefano Pessina, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Verizon Communications (VZ), Meta Platforms (META), NVIDIA (NVDA), Intel (INTC) and Humana (HUM).

Company Calendar

• Last Earnings: 6/26/2025
• Today: 7/03/2025
• Fiscal Year End: 8/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: RETAIL - DRUG STR
• Sub-Industry: Drug Retail
• Current Symbol: NASDAQ:WBA
• CIK: 1618921
• Web: www.walgreensbootsalliance.com
• Phone: (847) 315-3700
• Fax: 847-914-2804
• Employees: 312,000
• Year Founded: 2014

Price Target and Rating

• Average Stock Price Target: $10.59
• High Stock Price Target: $15.00
• Low Stock Price Target: $7.00
• Potential Upside/Downside: -7.7%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.83
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): ($7.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.17
• P/E Growth: 1.36
• Net Income: -$8.64 billion
• Net Margins: -4.07%
• Pretax Margin: -3.79%
• Return on Equity: 17.66%
• Return on Assets: 2.22%

Debt

• Debt-to-Equity Ratio: 0.96
• Current Ratio: 0.60
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $154.58 billion
• Price / Sales: 0.06
• Cash Flow: $5.74 per share
• Price / Cash Flow: 2.00
• Book Value: $8.33 per share
• Price / Book: 1.38

Miscellaneous

• Outstanding Shares: 865,561,000
• Free Float: 714,088,000
• Market Cap: $9.93 billion
• Optionable: Optionable
• Beta: 0.78